Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
05/2007
05/03/2007WO2007049820A1 Heterocyclic amide compound and use thereof
05/03/2007WO2007049736A1 Concentration crystallizer and method
05/03/2007WO2007049532A1 Aminodihydrothiazine derivative
05/03/2007WO2007048767A1 Squaric acid derivatives as inhibitors of histone deacetylase
05/03/2007WO2007029251A3 Polyalkylene glycol derivatives of 4- (phenylamino)quinazolines useful as irreversible inhibitors of epidermal gr0wth fact0r receptor tyrosine kinase
05/03/2007WO2007022488A3 Crystalline rosuvastatin intermediate
05/03/2007WO2007021858A3 Methods of making radiolabeled tracers and precursors thereof
05/03/2007WO2006105056A3 Insecticidal 2,4-diaminoquinazolines and related derivatives
05/03/2007WO2005094896A3 Targeted serotonin reuptake inhibitors
05/03/2007US20070100031 Ultraviolet light absorbers
05/03/2007US20070099938 Antistress drug and medical use thereof
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007US20070099917 Novel inhibitors and methods for their preparation
05/03/2007US20070099909 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
05/03/2007US20070099826 Treatment of diseases associated with the egr-1 enhancer element
05/03/2007DE19522145B4 7,8-Difluortetralin-Derivate und ihre Verwendung in flüssigkristallinen Mischungen 7,8-Difluortetralin derivatives and their use in liquid crystal mixtures
05/03/2007CA2628074A1 Aminodihydrothiazine derivative
05/03/2007CA2627497A1 Heterocyclic amide compound and use thereof
05/03/2007CA2625541A1 Ppar modulating biaromatic compounds
05/03/2007CA2623360A1 Squaric acid derivatives as inhibitors of histone deacetylase
05/02/2007EP1780197A1 5-substituted-2-phenylamino-benzamide as mek inhibitor
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1780191A1 Fluorene derivative and organic electroluminescent device using same
05/02/2007EP1778684A1 4-PIPERAZINYL-PYRIMIDINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D<sb>3</sb> RECEPTOR
05/02/2007EP1778681A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
05/02/2007EP1778670A2 Medicinal use of receptor ligands
05/02/2007EP1778640A1 Trifluoromethyl substituted benzamides as kinase inhibitors
05/02/2007EP1537111B1 Hetereoaryl nitrile derivatives
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
05/02/2007CN1956987A Heterocyclic compounds and their use as aldosterone synthase inhibitors
05/02/2007CN1956966A Quinazoline derivatives and therapeutic use thereof
05/02/2007CN1956721A Quinazolinone derivatives useful as vanilloid antagonists
05/02/2007CN1955182A Purine compound and use as cannabinoid receptor ligands
05/02/2007CN1955181A Purine compound and use as cannabinoid receptor ligands
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/02/2007CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
05/02/2007CN1313467C 6-(2,6-difluorophenyl)-triazolopyrimidines as fungecides
05/02/2007CN1313449C New quinazoline hind derivative, medicinal composition containing same and their use
05/02/2007CN1313439C Compounds and compositions for delivering active agents
05/01/2007US7211668 PNA monomer and precursor
05/01/2007US7211667 Trans,trans-1,3-butadiene-1,4-di-n-butyl-1-carboxyl-4-carboxamide; treating hypertension, associated with the decreased binding of magnesium to the plasma membranes of cells
05/01/2007US7211580 Compounds, compositions, and methods
05/01/2007US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV")
05/01/2007CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents
05/01/2007CA2162630C Sulfonamides
04/2007
04/26/2007WO2007047432A1 Sulfonamide derivatives as modulators of ppar
04/26/2007WO2007046075A1 Piperazine derivatives as antimalarial agents
04/26/2007WO2007025774A3 Cysteine protease inhibitors
04/26/2007WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity
04/26/2007US20070093660 Method for the production of statins
04/26/2007US20070093535 Vinyl phenyl derivatives as GLK activators
04/26/2007US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies
04/26/2007US20070092441 Fluoridation method
04/26/2007CA2626789A1 Pyrimidinones as casein kinase ii (ck2) modulators
04/26/2007CA2623213A1 Piperazine derivatives as antimalarial agents
04/25/2007EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives
04/25/2007EP1776588A1 Mass tags for quantitative analyses
04/25/2007EP1776350A1 NOVEL 2-AMINO-QUINAZOLINE DERIVATIVES USEFUL AS INHIBITORS OF ß-SECRETASE ( BACE )
04/25/2007EP1776349A2 2-amino-quinazoline derivatives useful as inhibitors of beta-secretase (bace)
04/25/2007EP1776110A1 Inhibitors of hsp90
04/25/2007EP1631533A4 Novel process for stereoselective reduction of beta-ketoesters
04/25/2007EP1142586B1 Use of chymase inhibitors against vascular lipid deposition
04/25/2007EP1040101B1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
04/25/2007CN1954446A 有机电致发光元件 Organic electroluminescent element
04/25/2007CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
04/25/2007CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use
04/25/2007CN1312134C 5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
04/25/2007CN1311829C Heteroaryl compounds which inhibit leukocyte adhesion mediated by alpha-4 integrins
04/24/2007USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations
04/24/2007US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
04/24/2007US7208493 Vasculostatic agents and methods of use thereof
04/24/2007CA2281545C N-heterocyclic derivatives as nos inhibitors
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007043094A2 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
04/19/2007WO2007042815A1 Compounds containing more than one human neutrophil elastase inhibiting moiety for use in the treatment of respiratory diseases
04/19/2007WO2007042810A1 Pyrimidine derivatives for the treatment of cancer
04/19/2007WO2007042806A1 Pyrimidine derivatives for the treatment of cancer
04/19/2007WO2007042782A1 Chemical compounds
04/19/2007WO2007042571A1 Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels
04/19/2007WO2006136408A3 Process for preparing pure amorphous rosuvastatin calcium
04/19/2007WO2006091771A8 Preparation of rosuvastatin
04/19/2007WO2006083553A3 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
04/19/2007US20070088058 3-(1(S)(4-chlorobenzyl)-2(S)-((2-hydroxy-2-methyl-1-phenylpropyl)amino)propyl)-benzonitrile; obesity; potentiation; antagonists
04/19/2007US20070088044 Quinazoline derivatives as antitumor agents
04/19/2007US20070088026 5-phenylpyrimidines, their preparation, intermediates for their preparation, and their use for controlling harmful fungi
04/19/2007CA2624566A1 Chemical compounds
04/18/2007EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents
04/18/2007EP1773824A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer
04/18/2007EP1773788A2 Quinazoline derivatives
04/18/2007EP1773787A1 Method for the production of 3-phenyl(thio)uracils and dithiouracils
04/18/2007EP1773775A1 Six-membered heterocycles useful as serine protease inhibitors
04/18/2007EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
04/18/2007EP1773345A2 Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
04/18/2007EP1773124A1 A use of sulfonanilides as agricultural and horticultural fungicide
04/18/2007EP1553949B1 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
04/18/2007EP1425276B1 Heterocyclic carboxamides and their use as fungicides
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1335900B1 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
04/18/2007EP1036066B1 Substituted pyrimidine and pyridine herbicides
04/18/2007CN1950479A 电致发光器件 Electroluminescent devices